Compugen (CGEN) EBT Margin Growth (1y) (2010 - 2026)
Compugen (CGEN) EBT Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Compugen |
189.59 Mn |
97.83 Mn |
352,000.00 |
3,916.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
3,916.00 |
| Dec 31, 2025 |
49,999.00 |
| Sep 30, 2025 |
-40,069.00 |
| Jun 30, 2025 |
-147,479.00 |
| Mar 31, 2025 |
2,919.00 |
| Dec 31, 2024 |
-47,151.00 |
| Dec 31, 2023 |
9,640.00 |
| Dec 31, 2016 |
97.00 |
| Sep 30, 2016 |
-817,161.00 |
| Jun 30, 2016 |
171,985.00 |
| Mar 31, 2016 |
-830,635.00 |
| Dec 31, 2015 |
1,705.00 |
| Sep 30, 2015 |
-263,008.00 |
| Jun 30, 2015 |
-293,789.00 |
| Mar 31, 2015 |
-107,713.00 |
| Dec 31, 2014 |
12,748.00 |
| Sep 30, 2014 |
-2,554.00 |
| Jun 30, 2014 |
1.37 Mn |
| Mar 31, 2014 |
229,169.00 |
| Dec 31, 2013 |
386,418.00 |
